Literature DB >> 18672354

Using fluorescent nanoparticles and SYBR Green I based two-color flow cytometry to determine Mycobacterium tuberculosis avoiding false positives.

Dilan Qin1, Xiaoxiao He, Kemin Wang, Weihong Tan.   

Abstract

A method using an improved two-color flow cytometric analysis by a combination of bioconjugated fluorescent silica nanoparticles and SYBR Green I (FSiNP@SG-FCM) has been developed for detection of pathogenic Mycobacterium tuberculosis. Antibody-conjugated nanoparticles were prepared by oriented immobilization of the anti-M. tuberculosis antibody onto Tris(2,2-bipyridyl)dichlororuthenium(II) hexahydrate-doped fluorescent silica nanoparticles (RuBpy-doped FSiNPs) through Protein A. M. tuberculosis was specially labeled with antibody-conjugated RuBpy-doped FSiNPs, then stained with a nucleic acid dye SYBR Green I to exclude background detrital particles, followed by multiparameter determination with flow cytometry. With this method, false positives caused by aggregates of nanoparticle-bioconjugates and nonspecific binding of nanoparticle-bioconjugates to background debris could be significantly decreased. This assay allowed for detection of as low as 3.5 x 10(3) and 3.0 x 10(4)cellsml(-1)M. tuberculosis in buffer and spiked urine respectively, with higher sensitivities than the FITC-based conventional flow cytometry. The total assay time including sample pretreatment was within 2h. This proposed FSiNP@SG-FCM method will be promising for rapid detection of M. tuberculosis or other pathogenic bacteria in clinical samples.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18672354     DOI: 10.1016/j.bios.2008.06.023

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  9 in total

Review 1.  Emerging nanotechnology-based strategies for the identification of microbial pathogenesis.

Authors:  Charalambos Kaittanis; Santimukul Santra; J Manuel Perez
Journal:  Adv Drug Deliv Rev       Date:  2009-11-13       Impact factor: 15.470

2.  Dual channel detection of ultra low concentration of bacteria in real time by scanning FCS.

Authors:  Ilaria Altamore; Luca Lanzano; Enrico Gratton
Journal:  Meas Sci Technol       Date:  2013-06-01       Impact factor: 2.046

Review 3.  Biosensing technologies for Mycobacterium tuberculosis detection: status and new developments.

Authors:  Lixia Zhou; Xiaoxiao He; Dinggeng He; Kemin Wang; Dilan Qin
Journal:  Clin Dev Immunol       Date:  2011-03-16

4.  A broad set of different llama antibodies specific for a 16 kDa heat shock protein of Mycobacterium tuberculosis.

Authors:  Anke K Trilling; Hans de Ronde; Linda Noteboom; Adèle van Houwelingen; Margriet Roelse; Saurabh K Srivastava; Willem Haasnoot; Maarten A Jongsma; Arend Kolk; Han Zuilhof; Jules Beekwilder
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

5.  Detection of Mycobacterium tuberculosis based on H37R(v) binding peptides using surface functionalized magnetic microspheres coupled with quantum dots – a nano detection method for Mycobacterium tuberculosis.

Authors:  Hua Yang; Lianhua Qin; Yilong Wang; Bingbo Zhang; Zhonghua Liu; Hui Ma; Junmei Lu; Xiaochen Huang; Donglu Shi; Zhongyi Hu
Journal:  Int J Nanomedicine       Date:  2014-12-17

6.  Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria.

Authors:  David A Barr; Charles Omollo; Mandy Mason; Anastasia Koch; Robert J Wilkinson; David G Lalloo; Graeme Meintjes; Valerie Mizrahi; Digby F Warner; Gerry Davies
Journal:  Sci Rep       Date:  2021-09-20       Impact factor: 4.379

Review 7.  Revisiting the methods for detecting Mycobacterium tuberculosis: what has the new millennium brought thus far?

Authors:  Thales Alves Campelo; Paulo Rafael Cardoso de Sousa; Lucas de Lima Nogueira; Cristiane Cunha Frota; Paulo Renato Zuquim Antas
Journal:  Access Microbiol       Date:  2021-08-02

Review 8.  Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.

Authors:  Surendra K Sharma; Alladi Mohan
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

Review 9.  Genome-wide host RNA signatures of infectious diseases: discovery and clinical translation.

Authors:  Harriet D Gliddon; Jethro A Herberg; Michael Levin; Myrsini Kaforou
Journal:  Immunology       Date:  2017-10-24       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.